RUNX1 and squamous cell carcinoma: Reduced RUNX1 expression was not related to pathologic stage (Figure S2), but was found more frequently in woman (Figure 4B) and in adenocarcinoma (Figure 4C) and was significantly associated with poor overall survival in adenocarcinoma (p = 0.005; Figure 4D) but not in squamous cell carcinoma (p = 0.87).